New immunotherapy strategies for patients with sarcomas: highlights from the 2023 ASCO annual meeting

Immunotherapy has revolutionized cancer treatment, but currently, immuno-oncology agents have not been approved for patients with soft tissue sarcomas. However, there is growing evidence suggesting that immuno...

Source: Journal of Hematology and Oncology - August 8, 2023 Category: Hematology Authors: Matthieu Roulleaux-Dugage and Antoine Italiano Tags: Editorial Source Type: research